IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Puissance Capital Management LP

Q3 2020 Holdings

Filed 2020-11-12 | 5 holdings | $169.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$152.0K38,01089.8%
Bellerophon Therapeutics Inc(BLPHUSD)COM NEW078771300$11.7K1,153,8466.9%
Ekso Bionics Hldgs Inc(EKSOEUR)COM282644301$3.7K774,4002.2%
Scynexis Inc(SCYX)COM NEW811292200$1.4K311,1430.8%
Kadmon Hldgs Inc(KDMN)COM48283N106$393100,1840.2%